The clinical relevance of ZIP1+ fibroblasts in lung cancer chemoresistance was further investigated in a cohort of 90 lung adenocarcinoma patients who underwent chemotherapy (Supplementary Data 5). This evidence concerns the gene SLC39A1 and lung carcinoma.